Does provider-initiated HIV testing and counselling lead to higher HIV testing rate and HIV case finding in Rwandan clinics?
Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF). PITC was introduced in six HFs in 2009-2010. HIV tes...
Saved in:
Published in | BMC infectious diseases Vol. 16; no. 24; p. 26 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
England
BioMed Central Ltd
25.01.2016
BioMed Central |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF).
PITC was introduced in six HFs in 2009-2010. HIV testing rate and case finding were compared between phase 1 (pre-PITC) and phase 3 (PITC period) for outpatient-department (OPD) attendees only, and for OPD and voluntary counseling & testing (VCT) departments combined.
Out of 26,367 adult OPD attendees in phase 1, 4.7% were tested and out of 29,864 attendees in phase 3, 17.0% were tested (p < 0.001). The proportion of HIV cases diagnosed was 0.25% (67/26,367) in phase 1 and 0.46% (136/29864) in phase 3 (p < 0.001). In multivariable analysis, both testing rate and case finding were significantly higher in phase 3 for OPD attendees. In phase 1 most of the HIV testing was done in VCT departments rather than at the OPD (78.6% vs 21.4% respectively); in phase 3 this was reversed (40.0% vs 60.0%; p < 0.001). In a combined analysis of VCT and OPD attendees, testing rate increased from 18.7% in phase 1 to 25.4% in phase 3, but case finding did not increase. In multivariable analysis, testing rate was significantly higher in phase 3 (OR 1.67; 95% CI 1.60-1.73), but case finding remained stable (OR 1.09; 95% CI 0.93-1.27).
PITC led to a shift of HIV testing from VCT department to the OPD, a higher testing rate, but no additional HIV case finding. |
---|---|
AbstractList | Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF). PITC was introduced in six HFs in 2009-2010. HIV testing rate and case finding were compared between phase 1 (pre-PITC) and phase 3 (PITC period) for outpatient-department (OPD) attendees only, and for OPD and voluntary counseling & testing (VCT) departments combined. Out of 26,367 adult OPD attendees in phase 1, 4.7 % were tested and out of 29,864 attendees in phase 3, 17.0 % were tested (p < 0.001). The proportion of HIV cases diagnosed was 0.25 % (67/26,367) in phase 1 and 0.46 % (136/29864) in phase 3 (p < 0.001). In multivariable analysis, both testing rate and case finding were significantly higher in phase 3 for OPD attendees. In phase 1 most of the HIV testing was done in VCT departments rather than at the OPD (78.6 % vs 21.4 % respectively); in phase 3 this was reversed (40.0 % vs 60.0 %; p < 0.001). In a combined analysis of VCT and OPD attendees, testing rate increased from 18.7 % in phase 1 to 25.4 % in phase 3, but case finding did not increase. In multivariable analysis, testing rate was significantly higher in phase 3 (OR 1.67; 95 % CI 1.60-1.73), but case finding remained stable (OR 1.09; 95 % CI 0.93-1.27). PITC led to a shift of HIV testing from VCT department to the OPD, a higher testing rate, but no additional HIV case finding. BACKGROUNDProvider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF).METHODSPITC was introduced in six HFs in 2009-2010. HIV testing rate and case finding were compared between phase 1 (pre-PITC) and phase 3 (PITC period) for outpatient-department (OPD) attendees only, and for OPD and voluntary counseling & testing (VCT) departments combined.RESULTSOut of 26,367 adult OPD attendees in phase 1, 4.7% were tested and out of 29,864 attendees in phase 3, 17.0% were tested (p < 0.001). The proportion of HIV cases diagnosed was 0.25% (67/26,367) in phase 1 and 0.46% (136/29864) in phase 3 (p < 0.001). In multivariable analysis, both testing rate and case finding were significantly higher in phase 3 for OPD attendees. In phase 1 most of the HIV testing was done in VCT departments rather than at the OPD (78.6% vs 21.4% respectively); in phase 3 this was reversed (40.0% vs 60.0%; p < 0.001). In a combined analysis of VCT and OPD attendees, testing rate increased from 18.7% in phase 1 to 25.4% in phase 3, but case finding did not increase. In multivariable analysis, testing rate was significantly higher in phase 3 (OR 1.67; 95% CI 1.60-1.73), but case finding remained stable (OR 1.09; 95% CI 0.93-1.27).CONCLUSIONPITC led to a shift of HIV testing from VCT department to the OPD, a higher testing rate, but no additional HIV case finding. Background Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF). Methods PITC was introduced in six HFs in 2009-2010. HIV testing rate and case finding were compared between phase 1 (pre-PITC) and phase 3 (PITC period) for outpatient-department (OPD) attendees only, and for OPD and voluntary counseling & testing (VCT) departments combined. Results Out of 26,367 adult OPD attendees in phase 1, 4.7 % were tested and out of 29,864 attendees in phase 3, 17.0 % were tested (p < 0.001). The proportion of HIV cases diagnosed was 0.25 % (67/26,367) in phase 1 and 0.46 % (136/29864) in phase 3 (p < 0.001). In multivariable analysis, both testing rate and case finding were significantly higher in phase 3 for OPD attendees. In phase 1 most of the HIV testing was done in VCT departments rather than at the OPD (78.6 % vs 21.4 % respectively); in phase 3 this was reversed (40.0 % vs 60.0 %; p < 0.001). In a combined analysis of VCT and OPD attendees, testing rate increased from 18.7 % in phase 1 to 25.4 % in phase 3, but case finding did not increase. In multivariable analysis, testing rate was significantly higher in phase 3 (OR 1.67; 95 % CI 1.60-1.73), but case finding remained stable (OR 1.09; 95 % CI 0.93-1.27). Conclusion PITC led to a shift of HIV testing from VCT department to the OPD, a higher testing rate, but no additional HIV case finding. Keywords: HIV testing rate, HIV case finding, PITC, Rwanda Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase HIV testing rate and HIV case finding among outpatients in Rwandan health facilities (HF). PITC was introduced in six HFs in 2009-2010. HIV testing rate and case finding were compared between phase 1 (pre-PITC) and phase 3 (PITC period) for outpatient-department (OPD) attendees only, and for OPD and voluntary counseling & testing (VCT) departments combined. Out of 26,367 adult OPD attendees in phase 1, 4.7% were tested and out of 29,864 attendees in phase 3, 17.0% were tested (p < 0.001). The proportion of HIV cases diagnosed was 0.25% (67/26,367) in phase 1 and 0.46% (136/29864) in phase 3 (p < 0.001). In multivariable analysis, both testing rate and case finding were significantly higher in phase 3 for OPD attendees. In phase 1 most of the HIV testing was done in VCT departments rather than at the OPD (78.6% vs 21.4% respectively); in phase 3 this was reversed (40.0% vs 60.0%; p < 0.001). In a combined analysis of VCT and OPD attendees, testing rate increased from 18.7% in phase 1 to 25.4% in phase 3, but case finding did not increase. In multivariable analysis, testing rate was significantly higher in phase 3 (OR 1.67; 95% CI 1.60-1.73), but case finding remained stable (OR 1.09; 95% CI 0.93-1.27). PITC led to a shift of HIV testing from VCT department to the OPD, a higher testing rate, but no additional HIV case finding. |
ArticleNumber | 26 |
Audience | Academic |
Author | Lammers, Judith Mugisha, Veronicah Bagiruwigize, Emmanuel Kayigamba, Felix R Asiimwe, Anita Van Santen, Daniëla Bakker, Mirjam I Schim Van Der Loeff, Maarten F De Naeyer, Ludwig |
Author_xml | – sequence: 1 givenname: Felix R surname: Kayigamba fullname: Kayigamba, Felix R email: fkaigamba@gmail.com organization: INTERACT, Kigali, Rwanda. fkaigamba@gmail.com – sequence: 2 givenname: Daniëla surname: Van Santen fullname: Van Santen, Daniëla email: dvsanten@ggd.amsterdam.nl, dvsanten@ggd.amsterdam.nl organization: Public Health Service of Amsterdam (GGD), Amsterdam, The Netherlands. dvsanten@ggd.amsterdam.nl – sequence: 3 givenname: Mirjam I surname: Bakker fullname: Bakker, Mirjam I email: M.Bakker@kit.nl organization: KIT Biomedical Research, Royal Tropical Institute (KIT), Amsterdam, The Netherlands. M.Bakker@kit.nl – sequence: 4 givenname: Judith surname: Lammers fullname: Lammers, Judith email: judith.lammers@amc.uva.nl organization: Academic Medical Center (AMC), Amsterdam, The Netherlands. judith.lammers@amc.uva.nl – sequence: 5 givenname: Veronicah surname: Mugisha fullname: Mugisha, Veronicah email: vm2208@columbia.edu organization: ICAP, Mailman School of Public Health, Columbia University, Kigali, Rwanda. vm2208@columbia.edu – sequence: 6 givenname: Emmanuel surname: Bagiruwigize fullname: Bagiruwigize, Emmanuel email: emmanuelb@theaccessproject.com organization: Ruhengeri hospital, Ministry of Health, Kigali, Rwanda. emmanuelb@theaccessproject.com – sequence: 7 givenname: Ludwig surname: De Naeyer fullname: De Naeyer, Ludwig email: ldnaeyer@yahoo.com organization: INTERACT, Kigali, Rwanda. ldnaeyer@yahoo.com – sequence: 8 givenname: Anita surname: Asiimwe fullname: Asiimwe, Anita email: anita.asiimwe@gmail.com organization: University of Rwanda, Kigali, Rwanda. anita.asiimwe@gmail.com – sequence: 9 givenname: Maarten F surname: Schim Van Der Loeff fullname: Schim Van Der Loeff, Maarten F email: mschimvdloeff@ggd.amsterdam.nl, mschimvdloeff@ggd.amsterdam.nl, mschimvdloeff@ggd.amsterdam.nl organization: Public Health Service of Amsterdam (GGD), Amsterdam, The Netherlands. mschimvdloeff@ggd.amsterdam.nl |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/26809448$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkktv1DAUhS1URB_wA9ggS2xgkRLbiR8bUFUeHalSpQLdWo5zkzHK2FM7KVDx43GYUjUSC1a27_3OsXx9DtGeDx4Qek7KY0Ikf5MIlUIVJeEFYXVd3D5CB6QSpKCMVXsP9vvoMKVvZUmEpOoJ2qdclqqq5AH69T5AwtsYblwLsXDejc6M0OKz1RUeIY3O99j4Ftsw-QTDMJ8HMC0eA167fg1xgcYs_sPPRWsS4M75du44jy-_547x2GYXZ9O7p-hxZ4YEz-7WI_T144cvp2fF-cWn1enJeWF5WY2FYEoZxg0TUinS8IoZKZtGSsVNaU0LFCzICpgUZa2a2jaqoxwaQltO61qwI_R257udmg20FvwYzaC30W1M_KmDcXrZ8W6t-3CjK0EFVSwbvLoziOF6yk_VG5dsnobxEKakieCloozT-a6XO7Q3A2jnu5Ad7Yzrk6oStZJM8Ewd_4My82M2zuZf7lyuLwSvF4LMjPBj7M2Ukl59vvx_9uJqyZIda2NIKUJ3PxVS6jlkehcynUOm55Dp26x58XCc94q_qWK_AYeqzYQ |
CitedBy_id | crossref_primary_10_1128_CMR_00064_18 crossref_primary_10_1016_j_heliyon_2020_e03515 crossref_primary_10_1186_s13104_019_4662_9 crossref_primary_10_1371_journal_pone_0246444 crossref_primary_10_1080_14659891_2019_1572801 crossref_primary_10_1186_s12939_023_02068_1 crossref_primary_10_1371_journal_pone_0214251 crossref_primary_10_1186_s13104_020_05234_8 crossref_primary_10_1155_2019_6057028 crossref_primary_10_1186_s12981_023_00541_z crossref_primary_10_1016_j_heliyon_2020_e05378 crossref_primary_10_1111_acem_14323 crossref_primary_10_3390_diagnostics11060950 |
Cites_doi | 10.1371/journal.pmed.1001496 10.1089/apc.2009.0005 10.1086/651477 10.1089/apc.2009.0269 10.1097/QAI.0b013e31814277c8 10.1097/QAI.0b013e3181fdb629 10.1097/QAD.0b013e32835b7048 10.1371/journal.pone.0027293 10.2471/BLT.10.084442 10.1371/journal.pone.0095459 10.1097/QAI.0b013e318030ffa9 10.1097/QAI.0b013e3181775926 10.2471/BLT.07.042580 10.1111/j.1365-3156.2011.02893.x 10.1007/s10461-006-9180-9 |
ContentType | Journal Article |
Copyright | COPYRIGHT 2016 BioMed Central Ltd. Kayigamba et al. 2016 |
Copyright_xml | – notice: COPYRIGHT 2016 BioMed Central Ltd. – notice: Kayigamba et al. 2016 |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION IOV ISR 7X8 5PM |
DOI | 10.1186/s12879-016-1355-z |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef Opposing Viewpoints Resource Center Gale In Context: Science MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1471-2334 |
EndPage | 26 |
ExternalDocumentID | A447598376 10_1186_s12879_016_1355_z 26809448 |
Genre | Evaluation Studies Research Support, Non-U.S. Gov't Journal Article |
GeographicLocations | Rwanda Netherlands |
GeographicLocations_xml | – name: Rwanda – name: Netherlands |
GroupedDBID | --- -A0 0R~ 23N 2WC 3V. 4.4 53G 5VS 6J9 6PF 7X7 88E 8C1 8FI 8FJ AAFWJ AAJSJ AAWTL ABDBF ABUWG ACGFO ACGFS ACIHN ACPRK ACRMQ ADBBV ADINQ ADRAZ ADUKV AEAQA AENEX AFKRA AFPKN AFRAH AHBYD AHMBA AHSBF AHYZX ALIPV ALMA_UNASSIGNED_HOLDINGS AMKLP AMTXH AOIJS BAPOH BAWUL BCNDV BENPR BFQNJ BMC BPHCQ BVXVI C24 C6C CCPQU CGR CS3 CUY CVF DIK DU5 E3Z EAD EAP EAS EBD EBLON EBS ECM EIF EJD EMB EMK EMOBN ESX F5P FYUFA GROUPED_DOAJ GX1 H13 HMCUK HYE IAO IHR INH INR IOV ISR ITC KQ8 M1P M48 M~E NPM O5R O5S OK1 P2P PGMZT PIMPY PQQKQ PROAC PSQYO RBZ RNS ROL RPM RSV SMD SOJ SV3 TR2 TUS UKHRP W2D WOQ WOW XSB AAYXX CITATION AFGXO 7X8 5PM |
ID | FETCH-LOGICAL-c604t-7399a36a378991b643a88bb8896a0cade2ece84e387059b5cb9f26eb12d625573 |
IEDL.DBID | RPM |
ISSN | 1471-2334 |
IngestDate | Tue Sep 17 21:12:25 EDT 2024 Thu Oct 24 23:20:01 EDT 2024 Wed Aug 14 18:53:47 EDT 2024 Tue Aug 13 05:21:10 EDT 2024 Sat Sep 28 21:35:52 EDT 2024 Sat Sep 28 21:06:48 EDT 2024 Thu Sep 12 18:51:40 EDT 2024 Sat Sep 28 08:05:05 EDT 2024 |
IsDoiOpenAccess | true |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 24 |
Language | English |
License | Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c604t-7399a36a378991b643a88bb8896a0cade2ece84e387059b5cb9f26eb12d625573 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
OpenAccessLink | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4727293/ |
PMID | 26809448 |
PQID | 1760923627 |
PQPubID | 23479 |
PageCount | 1 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_4727293 proquest_miscellaneous_1760923627 gale_infotracmisc_A447598376 gale_infotracacademiconefile_A447598376 gale_incontextgauss_ISR_A447598376 gale_incontextgauss_IOV_A447598376 crossref_primary_10_1186_s12879_016_1355_z pubmed_primary_26809448 |
PublicationCentury | 2000 |
PublicationDate | 2016-Jan-25 2016-1-25 20160125 |
PublicationDateYYYYMMDD | 2016-01-25 |
PublicationDate_xml | – month: 01 year: 2016 text: 2016-Jan-25 day: 25 |
PublicationDecade | 2010 |
PublicationPlace | England |
PublicationPlace_xml | – name: England – name: London |
PublicationTitle | BMC infectious diseases |
PublicationTitleAlternate | BMC Infect Dis |
PublicationYear | 2016 |
Publisher | BioMed Central Ltd BioMed Central |
Publisher_xml | – name: BioMed Central Ltd – name: BioMed Central |
References | 17211281 - J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):484-8 22114668 - PLoS One. 2011;6(11):e27293 18302828 - Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):79-84 22032300 - Trop Med Int Health. 2012 Jan;17(1):59-70 20059356 - AIDS Patient Care STDS. 2010 Feb;24(2):117-26 17096199 - AIDS Behav. 2007 Sep;11(5):753-8 19591606 - AIDS Patient Care STDS. 2009 Aug;23(8):619-23 20397960 - Clin Infect Dis. 2010 May 15;50 Suppl 3:S77-84 21556300 - Bull World Health Organ. 2011 May 1;89(5):328-335A 18302827 - Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):73-8 20067138 - Ethiop Med J. 2009 Oct;47(4):245-54 21189483 - J Acquir Immune Defic Syndr. 2011 Jan 1;56(1):e9-32 17667332 - J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):181-6 21385423 - BMC Public Health. 2011;11:151 18302825 - Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):63-8 18520677 - J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):190-5 23364442 - AIDS. 2013 Feb 20;27(4):617-26 24743295 - PLoS One. 2014;9(4):e95459 18438519 - Bull World Health Organ. 2008 Apr;86(4):302-9 20644629 - PLoS One. 2010;5(7):e11522 23966838 - PLoS Med. 2013 Aug;10(8):e1001496 18302826 - Int J Tuberc Lung Dis. 2008 Mar;12(3 Suppl 1):69-72 WHO (1355_CR4) 2009 S Dalal (1355_CR16) 2011; 6 WHO (1355_CR3) 2012 SM Topp (1355_CR15) 2011; 89 IV Bassett (1355_CR22) 2007; 46 A Rie Van (1355_CR8) 2008; 12 J Odhiambo (1355_CR12) 2008; 12 RK Wanyenze (1355_CR29) 2008; 86 B Hensen (1355_CR7) 2012; 17 WHO (1355_CR18) 2011 UNAIDS (1355_CR1) 2013 M Roura (1355_CR28) 2013; 27 NN Bock (1355_CR9) 2008; 12 A Corneli (1355_CR11) 2008; 12 1355_CR17 OA Ujiji (1355_CR6) 2011; 8 Ministry of Health, Rwanda (1355_CR5) 2012 AB Suthar (1355_CR27) 2013; 10 KJ Awosan (1355_CR25) 2013; 11 SM Topp (1355_CR20) 2010; 5 TW Steen (1355_CR21) 2007; 44 CO Cunningham (1355_CR23) 2009; 23 DS Pope (1355_CR10) 2008; 48 SM Kiene (1355_CR14) 2010; 24 WHO (1355_CR2) 2007 IV Bassett (1355_CR30) 2010; 50 DM Silvestri (1355_CR26) 2011; 56 S Girma (1355_CR13) 2009; 47 RF Kayigamba (1355_CR19) 2014; 9 D Nakanjako (1355_CR24) 2007; 11 |
References_xml | – volume: 10 year: 2013 ident: 1355_CR27 publication-title: PLoS Med doi: 10.1371/journal.pmed.1001496 contributor: fullname: AB Suthar – volume-title: Policy on collaborative TB/HIV activities Guidelines for national programmes and other stakeholders year: 2012 ident: 1355_CR3 contributor: fullname: WHO – volume: 8 start-page: 11 year: 2011 ident: 1355_CR6 publication-title: BMC Public Health contributor: fullname: OA Ujiji – volume: 12 start-page: 63 year: 2008 ident: 1355_CR12 publication-title: Kenya Int J Tuberc Lung Dis contributor: fullname: J Odhiambo – volume: 23 start-page: 619 year: 2009 ident: 1355_CR23 publication-title: AIDS Patient Care STDS doi: 10.1089/apc.2009.0005 contributor: fullname: CO Cunningham – volume: 12 start-page: 79 year: 2008 ident: 1355_CR11 publication-title: Int J Tuberc Lung Dis contributor: fullname: A Corneli – volume: 50 start-page: S77 year: 2010 ident: 1355_CR30 publication-title: Clin Infect Dis doi: 10.1086/651477 contributor: fullname: IV Bassett – volume-title: Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009 year: 2009 ident: 1355_CR4 contributor: fullname: WHO – volume: 24 start-page: 117 year: 2010 ident: 1355_CR14 publication-title: AIDS Patient Care STDS doi: 10.1089/apc.2009.0269 contributor: fullname: SM Kiene – volume: 12 start-page: 69 year: 2008 ident: 1355_CR9 publication-title: Int J Tuberc Lung Dis contributor: fullname: NN Bock – volume: 47 start-page: 245 year: 2009 ident: 1355_CR13 publication-title: Ethiop Med J contributor: fullname: S Girma – volume: 46 start-page: 181 year: 2007 ident: 1355_CR22 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e31814277c8 contributor: fullname: IV Bassett – volume: 56 start-page: e9 year: 2011 ident: 1355_CR26 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3181fdb629 contributor: fullname: DM Silvestri – volume: 27 start-page: 617 year: 2013 ident: 1355_CR28 publication-title: AIDS doi: 10.1097/QAD.0b013e32835b7048 contributor: fullname: M Roura – volume: 6 start-page: e27293 year: 2011 ident: 1355_CR16 publication-title: PLoS One doi: 10.1371/journal.pone.0027293 contributor: fullname: S Dalal – volume-title: Global AIDS Response. Epidemic Update and health sector progress towards Universal Access. Progress report year: 2011 ident: 1355_CR18 contributor: fullname: WHO – volume: 89 start-page: 328 year: 2011 ident: 1355_CR15 publication-title: Bull World Health Organ doi: 10.2471/BLT.10.084442 contributor: fullname: SM Topp – volume: 9 year: 2014 ident: 1355_CR19 publication-title: PLoS One doi: 10.1371/journal.pone.0095459 contributor: fullname: RF Kayigamba – volume-title: Global Report. UNAIDS Report on the global AIDS epidemic 2013 year: 2013 ident: 1355_CR1 contributor: fullname: UNAIDS – volume: 44 start-page: 484 year: 2007 ident: 1355_CR21 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e318030ffa9 contributor: fullname: TW Steen – volume: 5 year: 2010 ident: 1355_CR20 publication-title: Zambia PLoS One contributor: fullname: SM Topp – volume: 48 start-page: 190 year: 2008 ident: 1355_CR10 publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e3181775926 contributor: fullname: DS Pope – volume: 86 start-page: 302 year: 2008 ident: 1355_CR29 publication-title: Bull World Health Organ doi: 10.2471/BLT.07.042580 contributor: fullname: RK Wanyenze – volume: 17 start-page: 59 year: 2012 ident: 1355_CR7 publication-title: Trop Med Int Health doi: 10.1111/j.1365-3156.2011.02893.x contributor: fullname: B Hensen – volume: 11 start-page: 753 year: 2007 ident: 1355_CR24 publication-title: Uganda AIDS Behav doi: 10.1007/s10461-006-9180-9 contributor: fullname: D Nakanjako – volume: 11 start-page: 430 year: 2013 ident: 1355_CR25 publication-title: J AIDS and HIV Res contributor: fullname: KJ Awosan – ident: 1355_CR17 – volume: 12 start-page: 73 year: 2008 ident: 1355_CR8 publication-title: Congo Int J Tuberc Lung Dis contributor: fullname: A Rie Van – volume-title: Guidance on Provider-Initiated HIV Testing and Counselling in Health Facilities. Strengthening health services to fight HIV/AIDS year: 2007 ident: 1355_CR2 contributor: fullname: WHO – volume-title: Annual Report 2011-2012 year: 2012 ident: 1355_CR5 contributor: fullname: Ministry of Health, Rwanda |
SSID | ssj0017829 |
Score | 2.2443485 |
Snippet | Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to increase... Background Provider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to... BACKGROUNDProvider-initiated HIV testing and counselling (PITC) is promoted as a means to increase HIV case finding. We assessed the effectiveness of PITC to... |
SourceID | pubmedcentral proquest gale crossref pubmed |
SourceType | Open Access Repository Aggregation Database Index Database |
StartPage | 26 |
SubjectTerms | Adult AIDS Serodiagnosis - statistics & numerical data Ambulatory Care Counseling Diagnosis Female Health Services HIV infection HIV Infections - diagnosis HIV testing Humans Male Mass Screening Prevention Rwanda Voluntary Programs |
SummonAdditionalLinks | – databaseName: Scholars Portal Open Access Journals dbid: M48 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3da9RAEF9qBfFF6ve1VVYRBGE12ezng5SilqtQheqVvi3JZtMelI02OfqBf7wzSa42UsHX7BDudmZ2ZjK_-S0hr0orIGdLcxZChV-rQmBGSs4qW0J6qm1ZlTjgvPdFTWfi86E8XCHL662GDWxuLO3wPqnZ6cnb858XW-Dw7zuHN-pdA2esRtQPMupJyS5vkdscebkQySf-NBUgGNpu2EinjGeZGJqcN75iFKb-PqyvRasxkvJaaNpZI_eGnJJu90Zwn6yE-IDc2Ru65g_Jr491aOhy5o7NES8EKWZJp7sHtEWajXhE81hS3w-o44Q6PQHl07amxx0QZCSK7BKdPD70EAZp1_mGlXmk-2f4bSLSfuSy2XpEZjufvn-YsuHWBeZVIlqmIWXJM5VnGkqxtICMJTemKIyxKk8Qs8-DD0aEDDxd2kL6wlZcwZHPS6ilpM4ek9VYx_CUUA_nh6xUrhNfCV54W6WF5x4ZgkoNDyfkzXKT3Y-eXMN1RYlRrteIQwAaasRdTshLVIND0oqIqJijfNE0bvfrgdvuWAuh1Fb_Evq2PxJ6PQhVNWjN58MkAvxoJMMaSW6OJMH1_Gj5xdIkHC4hXi2GetG4VKsEUmfF9YQ86U3k6h9yZaCmFmZC9Mh4rgSQ8Xu8EufHHfO3wLa5zdb_Zys2yF2O9pyAsctNstqeLsIzSKDa4nnnFr8BRlEXSQ priority: 102 providerName: Scholars Portal |
Title | Does provider-initiated HIV testing and counselling lead to higher HIV testing rate and HIV case finding in Rwandan clinics? |
URI | https://www.ncbi.nlm.nih.gov/pubmed/26809448 https://search.proquest.com/docview/1760923627 https://pubmed.ncbi.nlm.nih.gov/PMC4727293 |
Volume | 16 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3da9RAEF_aCuKL-O1pPVYRBCG9fO1HnqQ9W67C1XLacviybDab9qDdFJNDKP7xzmySchF88WUfshNIMrM7Mzu_-YWQ90WWQswW6cDaEk-rrA0kY3FQZgWEpyIrygIbnOcnfHaWflmy5RZhfS-MB-2bfLXnrq733OrSYytvrs2kx4lNTufTFKuHWTLZJttgoH2K3pUOwOVlXfkyknxSwwYsEBKEdHuMBbdI_8slZDX4y58NX_T3jrzhkoZwyQ3_c_SIPOwCR7rfPuBjsmXdE3J_3pXGn5Lfnytb076xLlghKAjiyILOjs9pg1wa7oJqV1DTdqFjGzq9Ag3TpqKXHu0xEEUKCS-PFw34OurL2zCzcnTxCw8gHG37KutPz8jZ0eH36Szofq0QGB6mTSAgLtEJ14mAfCvKISzRUua5lBnXIQLzY2usTG0Cy5llOTN5VsYc9vW4gISJieQ52XGVsy8JNbBJsJJrEZoyjXOTlVFuYoM0QIWAiyPysf_I6qZl0FA-85BctcpRiDJD5ajbEXmHalDITOEQ-nKh13Wtjr-eq31PTQj5NP-X0LfFQOhDJ1RWoDWju3YDeGhkvBpI7g4kYX2ZwfTb3iQUTiEozdlqXatI8BDiYx6LEXnRmsjdG_YmNiJiYDx3AkjrPZwBa_f03p11v_rvO1-TBzHaexgFMdslO83PtX0DoVOTj2HBLAWMchqNyb2Dw5PTxdgfQ8A4TyWMi4MfY7-g_gAaYh9D |
link.rule.ids | 230,315,730,783,787,867,888,24332,27938,27939,31734,33281,33759,53806,53808 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3daxQxEB9qBfXF7-pp1SiCIOzdfiXZfZJSLXfaq1Lbo29hk822h22uuHsIh3-8M_tRbgs-6GtmFhIyyczs_OYXgLd5GmPMFmSetQX9rbLWSzgPvSLNMTyVaV7k1OA8PRDj4_jzCT_ZAN71wtSgfaPnQ3d-MXTzsxpbeXlhRh1ObPRtuhtT9TCNRjfgJp5XX3RJels8QKeXtgXMIBGjEq9gSaAgItzj3FsRAbBIMK-hR3_WvNH1O3nNKfUBk2seaO8ezLq5N8CTH8NlpYdmdY3W8Z8Xdx_utjEp22nED2DDuodwa9pW3R_B748LW7KuZ8-bE94IQ9ScjSczVhFNhztlmcuZaRrcqcOdnaPxsGrBzmogSU-V2ClqfRo06EZZXTlHydyxw1_0b8OxpmWz_PAYjvc-He2OvfbVBs8IP648iSFPFokskpjKBRojnixJtE6SVGQ-Yf5Da2wS2whvCp5qbnRahAJdRphjLsZltAWbbuHsU2AG7x9eiEz6pohDbdIi0CY0xDCUSxwcwPtu99RlQ86h6qQmEarZdUUANtp1tRrAG9pfRaQXjlA1p9myLNXk60zt1KyHmKqLvyl9P-wpvWuVigWag8naTgacNJFp9TS3e5p4dE1P_LqzNUUiwrs5u1iWKpDCx9BbhHIATxrbu1phZ7sDkD2rvFIgxvC-BG2tZg5vbevZf3_5Cm6Pj6b7an9y8OU53AnpUPmBF_Jt2Kx-Lu0LjNAq_bI-j38A6I87EQ |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9RAFB60QvHFendr1VEEQcjmOpc8SWlddtWtpdpS-jJkJpN2sZ1dTBZh8cd7Ti5lU_Clr5kvMGHOzDkn5zvfEPI-TxOI2cLMs7bAv1XWepKxyCvSHMJTkeZFjg3O0wM-Pk6-nLLTtau-atK-0bOhu7wautlFza1cXBm_44n5h9O9BKuHaewv8sK_S-7Bng1kl6i3BQRwfGlbxAwl90s4hgUSg1B0jzFvhSLAXEJugxf_rHmkm-fymmPqkybXvNBoi5x182_IJ7-Gy0oPzeqGtOOtPvAhedDGpnS3gTwid6x7TDanbfX9Cfm7P7cl7Xr3vBnyjiBUzel4ckIrlOtw5zRzOTVNozt2utNLMCJazelFTSjpQVGlosbjQwPulNYVdBiZOXr0B_9xONq0bpafnpLj0eefe2Ovvb3BMzxIKk9A6JPFPIsFpHShhsgnk1JrKVOeBcj9j6yxMrExnBgs1czotIg4uI4oh5yMifgZ2XBzZ18QauAcYgXPRGCKJNImLUJtIoNKQ7mAhwPysVtBtWhEOlSd3EiumpVXSGTDlVerAXmHa6xQ_MIhu-Y8W5almnw_Ubu1-iGk7Px_oB9HPdCHFlTMwSRM1nY0wKRRVKuH3OkhYQub3vDbzt4UDiHvzdn5slSh4AGE4DwSA_K8sb_rL-zsd0BEzzKvAagc3h8Be6sVxFv72r71m2_I5uH-SH2bHHx9Se5HuK-C0IvYDtmofi_tKwjUKv263pL_ALvbPZE |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Does+provider-initiated+HIV+testing+and+counselling+lead+to+higher+HIV+testing+rate+and+HIV+case+finding+in+Rwandan+clinics%3F&rft.jtitle=BMC+infectious+diseases&rft.au=Kayigamba%2C+Felix+R&rft.au=Van+Santen%2C+Dani%C3%83%C2%ABla&rft.au=Bakker%2C+Mirjam+I&rft.au=Lammers%2C+Judith&rft.date=2016-01-25&rft.pub=BioMed+Central+Ltd&rft.issn=1471-2334&rft.eissn=1471-2334&rft.volume=16&rft.issue=24&rft_id=info:doi/10.1186%2Fs12879-016-1355-z&rft.externalDBID=IOV&rft.externalDocID=A447598376 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1471-2334&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1471-2334&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1471-2334&client=summon |